Clinical Trials in Philadelphia

Showing 14001-14020 of 17,926 trials

Evaluating Incentive Designs to Increase Physical Activity Goal Adherence in a Wellness Program

NCT02629601

This is a 4-week, five-arm, randomized, controlled trial to compare a standard wellness incentive program for physical activity to four other designs.

Physical Activity

University of PennsylvaniaStarted May 2016

Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

NCT01070836

The primary objective of this study is to demonstrate that the incidence of progressive multifocal Leukoencephalopathy (PML) in natalizumab-treated participants who do not have detectable antibodies to John Cunningham virus (JCV) (antibody negative) is lower than in participants who have detectable antibodies to JCV (antibody positive). The secondary objectives of this study are to: Estimate the incidence of PML in natalizumab-treated participants who are anti-JCV antibody negative and anti-JCV antibody positive, based on a meta-analysis of data obtained from this study and other data sources; Define the prevalence of anti-JCV antibody in relapsing multiple sclerosis (MS) participants receiving natalizumab within the TYSABRI Outreach: United Commitment to Health (TOUCH) Prescribing Program; Determine changes in anti-JCV antibody status over time.

Relapsing Multiple Sclerosis

Biogen35,895 participantsStarted Mar 2010

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Cullman, Alabama, United States +475 more locations

Evaluating Incentive Designs to Increase Physical Activity Goal Adherence in a Wellness Program

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Find Trials by Condition in Philadelphia

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Effect of Reminders on Adherence

Infusional C-myb ASODN in Advanced Hematologic Malignancies

Treadmill Training for Spinal Cord Injury

A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis

Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of AZD5213 in Adolescents With Tourette's Disorder

An Observational Study of Childhood Food Allergy

Detecting EGFR T790M Mutations From Circulating Tumor Cells

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure

A Prospective Trial to Identify Biomarkers Involved in the Transition From Acute to Persistent Chronic Low Back Pain

A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors

A Study of Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment